Type 2 diabetes mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: The intervention group in this research will receive whole chicory plant powder. Participants take 3 gr chicory powder daily as 6 capsules and take them 2 times a d
Sponsors
Bandare-abbas University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: patients with type 2 diabetes (T2DM) age from 30 to 65 years BMI less than 30kg / m ^ 2 They have been diagnosed for diabetes at least one year before entering into the study Taking anti-diabetes drugs (the type of medicine is not a criterion) not using insulin
Exclusion criteria
Exclusion criteria: Addiction to alcohol and drugs Abnormal level of liver enzymes or BUN or creatinine Any change in the type, or dosage of antidiabetic drugs or administration of insulin The presence of special diseases or condition (eg, nephropathy, thyroid disease, pregnancy, etc.) Taking medications that affect blood sugar levels Failure to follow the study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose. Timepoint: investigate fasting blood glucose at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer.;Hemoglobin A1c. Timepoint: investigate Hemoglobin A1c at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer.;Homeostatic Model Assessment of Insulin Resistance. Timepoint: investigate Homeostatic Model Assessment of Insulin Resistance at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum level of triglyceride. Timepoint: investigate serum level of triglyceride at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer.;Serum level of total cholesterol. Timepoint: investigate serum level of total cholesterol at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer.;Serum level of low density lipoprotein cholesterol. Timepoint: investigate serum level of low density lipoprotein cholesterol at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer.;Serum level of high density lipoprotein cholesterol. Timepoint: investigate serum level of high density lipoprotein cholesterol at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer.;Serum level of Aspartate Aminotransferase. Timepoint: investigate serum level of Aspartate Aminotransferase at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer.;Serum level of Alanine Aminotransferase. Timepoint: investigate serum level of Alanine Aminotransferase at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer.;Serum level of alkaline phosphatase. Timepoint: investigate serum level of alkaline phosphatase at the first and end of research. Method of measurement: Autoanalyzer spectrophotometer.;Blood pressure. Timepoint: investigate blood pressure at the first and end of research. Method of measurement: The mercury manometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Hendijani
Bandare-abbas University of Medical Sciences
Outcome results
None listed